Advanced Medical Solutions Group Plc · LSE:AMS
Advanced Medical Solutions — Shareholder Meeting (June 2016)
7 slides from Advanced Medical Solutions's shareholder meeting presentation, Jun 2, 2016
Slide 1: Annual General Meeting 2 June 2016
ANNUAL GENERAL MEETING 2 JUNE, 2016 Chris Meredith, Chief Executive Officer
Slide 2: 2015 Financial Highlights
2015 Financial Highlights Adjusted operating profit and margin is shown before amortisation of acquired intangibles Growth at Reported 2015 2014 constant growth currency Group revenue (£ m) 68.6 63.0 9% 11% Adjusted operating margin (%) 25.4 24.7 70 bps - Adjusted profit before tax (£ m) 17.4 15.6 1
Slide 3: 2015 Business Highlights
2015 Business Highlights • Good sales progress across all Business Units on a constant currency basis • Strong performance in the US with LiquiBand® tissue adhesive range – revenue up 79% • Market share by volume increased to 17% • ActivHeal® continues to make good progress in the NHS – revenue up 8
Slide 4: Branded Distributed: 2015
Branded Distributed: 2015 Revenue up 38% to £14.6m (2014 : £10.6m) LiquiBand® • US sales up 79% to £8.0m • Market share now 16% in hospital sector and 22% in non-hospital sector – 17% market share overall • Multiple formulations and differentiated devices contributing to sales growth • Extended clai
Slide 5: Branded Direct: 2015
Branded Direct: 2015 Revenue up 3% to £22.3m (2014: £23.2m) A year of investment with a number of senior management hires ActivHeal® • Sales up 8% to £6.4m • Antimicrobial and atraumatic foam dressings extending product range RESORBA® • Sales flat • Targeting smaller accounts – enabling easier hospi
Slide 6: OEM: 2015
OEM: 2015 Revenue up 8% to £27.7m (2014: £25.3m) • Silver alginate up 10% to £15.5m, good progress being made by multiple partners in EU and US • CE approval September 2015 for non-adhesive antimicrobial foam dressings containing Polyhexamethylene Biguanide (PHMB) - launches planned for 2016 • Base
Slide 7: Summary & Outlook
Summary & Outlook • Revenue growth of 11% with good profitability and cash generation • Strong performance from LiquiBand® in the US and market share by volume now 17% • LiquiBand® Fix8™ performing well, launched in 20 countries and delivered £1.0m of sales • Continued investment in management team
Advanced Medical Solutions Group — Shareholder Meeting (June 2016) on 6ix